作者
Désirée J. Wendering,Leila Amini,Stephan Schlickeiser,Martí Farrera-Sal,Sarah Schulenberg,Lena Peter,M. Mai,Tino Vollmer,Weijie Du,Maik Stein,Frederik Hamm,Alisier Malard,Carla N. Castro,Mingxing Yang,Ramon Ranka,Timo Rückert,Pawel Durek,Frederik Heinrich,Gilles Gasparoni,Abdulrahman Salhab,Jörn Walter,Dimitrios L. Wagner,Mir‐Farzin Mashreghi,Sybille Landwehr-Kenzel,Julia K. Polansky,Petra Reinke,Hans‐Dieter Volk,Michael Schmueck‐Henneresse
摘要
Regulatory T cells (T reg cells) hold promise for sustainable therapy of immune disorders. Recent advancements in chimeric antigen receptor development and genome editing aim to enhance the specificity and function of T reg cells. However, impurities and functional instability pose challenges for the development of safe gene-edited T reg cell products. Here, we examined different T reg cell subsets regarding their fate, epigenomic stability, transcriptomes, T cell receptor repertoires, and function ex vivo and after manufacturing. Each T reg cell subset displayed distinct features, including lineage stability, epigenomics, surface markers, T cell receptor diversity, and transcriptomics. Earlier-differentiated memory T reg cell populations, including a hitherto unidentified naïve-like memory T reg cell subset, outperformed late-differentiated effector memory–like T reg cells in regulatory function, proliferative capacity, and epigenomic stability. High yields of stable, functional T reg cell products could be achieved by depleting the small effector memory–like T reg cell subset before manufacturing. Considering T reg cell subset composition appears critical to maintain lineage stability in the final cell product.